The future of treating canine parvovirus is coming. With our newest innovation, the Canine Parvovirus Monoclonal Antibody, the conversation between pet parents and veterinarians will change. The Canine Parvovirus Monoclonal Antibody is expected to begin shipping in the coming weeks, pending individual state approvals.
✅ If you’re a pet parent… Traditional parvovirus treatments can consist of 24/7 care, 35 days of hospitalization, high pet owner costs and emotional stress, with still no guaranteed outcomes. The Canine Parvovirus Monoclonal Antibody offers a targeted solution with predictable outcomes. Overall, it’s less time, less worry and less labor – helping dogs feel better faster.
✅ If you’re a veterinarian… The Canine Parvovirus Monoclonal Antibody is easy to administer, giving you the potential to save days of labor and stress associated with managing the symptoms of this potentially deadly and contagious disease.

Learn more about Elanco’s Canine Parvovirus Monoclonal Antibody: https://www.FightParvo.com